CONMED (CNMD) → Stock, financial statements


117.62 USD -7.37 (-5.17%)
Dividends News
  • CNMD Ticker
  • 🇺🇸 NASDAQ Exchange
  • 3,100 Employees
2 rated
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon
comming soon

Financial statements — CONMED

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
20 ← 16 2020 2019 2018 2017 2016
Total Revenue
860M 960M 860M 800M 760M
Cost Of Revenue
400M 430M 390M 370M 360M
Gross Profit
460M 520M 470M 430M 410M
Research and Development
40M 45M 42M 32M 32M
Selling General and Admin
370M 400M 360M 350M 340M
Operating Expense
820M 880M 790M 750M 730M
Operating Income
46M 79M 71M 47M 38M
Other Income Expense Net
0 0 0 0 0
46M 79M 71M 47M 38M
Interest Income
44M 43M 21M 18M 15M
Pretax Income
1.6M 31M 51M 29M 19M
Income Tax
-7.9M 2.6M 9.8M -27M 4.7M
Minority Interest
0 0 0 0 0
Net Income
9.5M 29M 41M 55M 15M
Net Income Basic
9.5M 29M 41M 55M 15M
20 ← 16 2020 2019 2018 2017 2016
Current cash
27M 26M 18M 33M 27M
Short term investments
17M 18M 21M 16M 19M
180M 190M 180M 170M 150M
190M 160M 150M 140M 140M
Other current assets
17M 18M 21M 16M 19M
Current assets
420M 400M 370M 360M 330M
Long term investments
1.3B 1.4B 990M 1B 1M
Property plant equipment
110M 120M 110M 120M 120M
620M 620M 400M 400M 400M
Intangible assets
500M 530M 410M 410M 420M
Other assets
97M 100M 63M 63M 56M
Total assets
1.8B 1.8B 1.4B 1.4B 1.3B
Accounts payable
53M 56M 53M 42M 42M
Current long term debt
18M 14M 18M 15M 10M
Other current liabilities
120M 120M 89M 93M 62M
Total current liabilities
190M 190M 160M 150M 110M
Long term debt
740M 760M 440M 470M 490M
Other liabilities
59M 47M 26M 27M 27M
Minority Interest
0 0 0 0 0
Total Liabilities
1B 1.1B 710M 730M 750M
Common stock
29M 28M 28M 28M 28M
Retained earning
460M 470M 460M 440M 410M
Treasury stock
-68M -81M -89M -94M -97M
Capital surplus
Shareholder equity
710M 710M 660M 630M 580M
Net tangible assets
-410M -440M -150M -190M -240M
20 ← 16 2020 2019 2018 2017 2016
Net Income
9.5M 29M 41M 55M 15M
73M 72M 62M 59M 55M
Changes in receivables
-12M 7.5M 15M 19M 13M
Changes in inventories
30M 10M 13M 5.6M -31M
Cash change
1.5M 8.3M -15M 5.2M -45M
Cash flow
65M 95M 75M 66M 38M
Capital expenditures
-13M -20M -17M -13M -15M
Investing activity other
Total investing cash flows
-14M -390M -17M -29M -270M
Dividends paid
Net borrowings
710M 730M 420M 440M 450M
Other financing cash flows
Cash flow financing
-52M 300M -72M -35M 180M
Exchange rate effect

Operates as a medical technology company, which provides surgical devices and equipment for minimally invasive procedures and monitoring